Oramed Pharmaceuticals
Biotechnology
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

$87.5M

Market Cap • 11/18/2024

2002

(22 years)
Founded

2007

(17 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

New York

Headquarters • New York